BIO-PATH HOLDINGS, INC. Cash Flow Statement
BPTH|7 years of annual SEC 10-K data (FY2012-FY2018)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
BIO-PATH HOLDINGS, INC. used $6M in operating cash flow and negative free cash flow of $6M in FY2018.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -25.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Net Income | -$8.6M | -$7.0M | -$6.8M | -$5.5M | -$4.5M | -$3.3M | -$2.6M |
| Operating Cash Flow | -$6.1M | -$8.0M | -$8.1M | -$5.0M | -$3.8M | -$9.4M | -$2.0M |
| Capital Expenditures | $17.0K | $538.0K | $338.0K | $0 | $123.0K | $0 | $0 |
| Free Cash Flow | -$6.1M | -$8.5M | -$8.5M | -$5.0M | -$3.9M | -$9.4M | -$2.0M |
| FCF Margin | - | -22959.5% | -65276.9% | - | - | - | - |